2. For Visitors
  3. NU Research
  4. Highlights
  5. Global first determination of crystal structure of gastric proton pump


Global first determination of crystal structure of gastric proton pump

  • Read in Japanese
  • 2018/04/17

Cellular and Structural Physiology Institute / Graduate School of Pharmaceutical Sciences

Associate Prof. Kazuhiro Abe, Assistant Prof. Katsumasa Irie, Researcher Hanayo Nakanishi, and Endowed Chair (Research Institutes) Yoshinori Fujiyoshi

Fig. 1: Gastric proton pump, H+,K+-ATPase
The gastric proton pump, also known as H+,K+-ATPase, is expressed on the surface of the stomach to secrete the gastric acid indispensable for digestion of proteins in food. However, too much acid secretion induces ulcers. The gastric proton pump uptakes protons from the neutral cytoplasm (pH 7) to the acidic milieu of the stomach (pH 1) driven by ATP as an energy source. Thus, it is an important drug target for acid-related diseases. © Kazuhiro Abe

Nagoya University-centered researchers first in world to determine crystal structure of gastric proton pump responsible for gastric acid secretion

Nagoya, Japan - The highly acidic environment in the stomach is essential for digestion. Furthermore, it acts as an important barrier to pathogens invading via the oral route. However, excessive stomach acidification leads to ulcers. Although this is not a life-threatening condition, it can considerably impair the health of affected individuals. Acid suppression in combination with antibiotics is the recognized treatment to eradicate the bacteria Helicobacter pylori, a risk factor for gastric cancer. This environment of pH1 is regulated by the gastric H+ (hydrogen ions), K+ (potassium ions)-ATPase, a class of enzymes that catalyze H+ transport from neutral cytosolic solution (pH 7) to the acidic gastric lumen (pH 1) fueled by cellular energy source ATP (Fig.1). Hence, gastric H+, K+-ATPase are prominent target for drugs that treat excess stomach acid secretion.

The main research question in this area of study is how such a highly acidic environment can be attained in the stomach. To address this question, one must first elucidate the structure of H+, K+-ATPase, which is exactly what a team of Nagoya University-centered researchers set out to do - and achieved. The team recently published their findings in Nature.

"In our study, we used X-ray crystallography to determine the structures of gastric H+, K+-ATPase bound to two proton pump inhibitors, vonoprazan and SCH28080," study first author Kazuhiro Abe explains. "This information is important for both the refinement of existing drugs and the discovery of new drugs."

X-ray crystallography is a technique that uses x-ray diffraction patterns to determine high-resolution, three-dimensional structures of molecules such as proteins, small organic molecules, and materials.

The team successfully solved the crystal structure of H+, K+-ATPase in complex with either vonoprazan or SCH28080 to a resolution of 2.8 Å - one that is high enough to reveal that the drugs partially overlapped but had clearly distinct binding modes in their binding sites found in the middle of a conduit running from the gastric lumen to the cation-binding site (Fig.2).

Fig. 2 : Blocking the cation transport pathway by P-CAB
The gastric proton pump export H+ into the gastric lumen, which follows uptake of K+ into the cytoplasm. Left panel shows slices of the transmembrane domain of the gastric proton pump. In the present structure, P-CAB (vonoprazan, magenta) binds in the middle of cation transport pathway (conduit), which blocks cation transport. The enlarged view of vonoprazan (magenta) binding site reveals its tight binding to the protein (right). © Kazuhiro Abe

"The crystal structures suggest that the tight configuration at the cation-binding site lowers the pKa (a measure of acid strength) value of glutamic acid at residue 820 sufficiently to enable the release of a proton even into the pH 1 environment of the stomach (Fig.3)," senior author Yoshinori Fujiyoshi says. "These structures define the molecular interaction between P-CABs (K+-competitive acid blockers) and H+, K+-ATPase, and reveal how H+, K+-ATPase expels H+ into the stomach even at pH1. Such information will contribute significantly to the knowledge base for drug discovery for conditions related to excessive stomach acidification."

Fig. 3: Proton extrusion model (A Billiard model)
Unusually tight coordination of two glutamates (Glu795 and Glu820) and a lysine (Lys791) at the cation binding site was revealed in the crystal structure. A single H+ bound to Glu820 is extruded by the positive charge of Lys791, even for the highly acidic gastric lumen (left). This mechanism is likened to a billiard model (right). A positive charge at the lysine residue acts as a "cue" that shoots the "yellow ball" (H+) at Glu820. This yellow ball in turn strikes another H+ (green ball) at Glu795 which is exposed to the cation transport pathway. Finally, a single ball (H+) is in the pocket (exit to the gastric lumen). © Kazuhiro Abe

The article, "Crystal structures of the gastric proton pump" was published in Nature at DOI: 10.1038/s41586-018-0003-8.

Authors: Kazuhiro Abe1,2,3, Katsumasa Irie1,2, Hanayo Nakanishi1,3, Hiroshi Suzuki4 & Yoshinori Fujiyoshi1,3,5

1 Cellular and Structural Physiology Institute, Nagoya University
2 Graduate School of Pharmaceutical Sciences, Nagoya University
3 Japan Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation
4 Laboratory of Molecular Electron Microscopy, The Rockefeller University
5 CeSPIA Inc., Tokyo

Related Links:

Dr. Kazuhiro Abe, Laboratory of Structural Physiology, Cellular and Structural Physiology Institute, Nagoya University

Cellular and Structural Physiology Institute, Nagoya University

Media Coverage:



Asia Research News



Technology Networks

Long Room


Funding: This work was supported by Grants-in-Aid for Scientific Research (B), CREST from JST (JPMJCR14M4), and Basis for Supporting Innovative Drug Discovery and Life Science Research (to K.A.); Grants-in-Aid for Scientific Research (S), the Japan New Energy and Industrial Technology Development Organization (NEDO), and the Japan Agency for Medical Research and Development (AMED) (to Y.F.).


To the Top of This Page